SCHEMBL30938403

SCHEMBL30938403

CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccccc3OC)C2)C1c1cccc(O)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.55
USP2 O75604 1/20 0.55
MAPK1 P28482 1/20 0.55
RAB9A P51151 1/20 0.55
KDM4E B2RXH2 12/20 0.52
POLB P06746 4/20 0.52
LMNA P02545 2/20 0.52
AGTR1 P30556 1/20 0.52
GAA P10253 5/20 0.51
HPGD P15428 5/20 0.50
KIF11 P52732 1/20 0.49
HSD17B10 Q99714 5/20 0.48
CASP1 P29466 4/20 0.48
CASP7 P55210 4/20 0.48
BAP1 Q92560 1/20 0.48
HTT P42858 1/20 0.48
DHFR P00374 1/20 0.46
MAPT P10636 1/20 0.45
TP53 P04637 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31634750 1.00 ALDH1A1 (0.55) ALDH1A1USP2MAPK1RAB9AKDM4E
SCHEMBL30938430 1.00 ALDH1A1 (0.55) ALDH1A1USP2MAPK1RAB9AKDM4E
SCHEMBL644336 0.93 KDM4E (0.54) ALDH1A1USP2MAPK1RAB9AKDM4E
SCHEMBL29392482 0.93 KDM4E (0.54) ALDH1A1USP2MAPK1RAB9AKDM4E
SCHEMBL30195593 0.93 KDM4E (0.54) ALDH1A1USP2MAPK1RAB9AKDM4E
SCHEMBL30938397 0.93 KDM4E (0.54) ALDH1A1USP2MAPK1RAB9AKDM4E
SCHEMBL30938391 0.93 KDM4E (0.54) ALDH1A1USP2MAPK1RAB9AKDM4E
SCHEMBL31634746 0.93 KDM4E (0.55) ALDH1A1USP2MAPK1RAB9AKDM4E
SCHEMBL30938448 0.93 KDM4E (0.55) ALDH1A1USP2MAPK1RAB9AKDM4E
SCHEMBL30938399 0.93 KDM4E (0.55) ALDH1A1USP2MAPK1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594304-A2 IMMUNOSUPPRESSIVE COMPOUNDS Universität Basel Vizerektorat Forschung (CH) 2025-08-06 EP claimed
WO-2024069007-A2 IMMUNOSUPPRESSIVE COMPOUNDS UNIVERSITÄT BASEL (CH) 2024-04-04 WO claimed
US-20260102387-A1 IMMUNOSUPPRESSIVE COMPOUNDS UNIV BASEL (CH) 2026-04-16 US disclosed
EP-4594304-A2 IMMUNOSUPPRESSIVE COMPOUNDS Universität Basel Vizerektorat Forschung (CH) 2025-08-06 EP disclosed
WO-2024069007-A2 IMMUNOSUPPRESSIVE COMPOUNDS UNIVERSITÄT BASEL (CH) 2024-04-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260102387-A1 IMMUNOSUPPRESSIVE COMPOUNDS CHP1, BRD3, IRF3 ALDH1A1 4040/4885USP2 2456/4885MAPK1 595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.